1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 1:Clinical backgrounds, symptoms, and risk factors in posterior circulation ischemia and control groups
PCI Group Control Group P Clinical Backgrounds N (male vs female) 21 (10:11) 16 (11:5) NS† Age range, y (mean) 41–80 (61.3) 40–85 (61.6) NS* Body mass index,kg/m2 24.8 ± 4.0 22.7 ± 3.9 NS* SBP, mm Hg Intermittent 135.0 ± 18.1 NS* Attack 148.6 ± 19.6 132.3 ± 12.9 <.001 Clinical Symptoms Paroxysmal vertigo (with nystagmus) 5 (3) 0 Paroxysmal dizziness (with nystagmus) 16 (1) 0 Hearing loss 2 2 Headache 0 1 Chronic neurologic deficit 0 3 Transient neurologic deficit 4 0 Risk Factors for Cerebral Blood Flow Hypertension 11 3 NS† Diabetes Mellitus 1 0 NS† Hyperlipidemia 7 7 NS† Smoking 3 4 NS†
Note.—PCB, posterior circulation ischemia; SBP, systolic blood pressure; hypertension, SBP > 140 mm Hg; diabetes mellitus, fasting blood glucose level > 200 mg/dL; hyperlipidemia, total blood cholesterol level > 200 mg/dL or neutral fat > 160 mg/dL; smoker, habitual smoking during study.
* Student t test.
† Fisher exact probability test.